• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性肝硬化门腔分流术后肝脏铁和锌的浓度

Hepatic iron and zinc concentrations after portacaval shunting for nonalcoholic cirrhosis.

作者信息

Adams P C, Bradley C, Frei J V

机构信息

Department of Medicine, University Hospital, University of Western Ontario, London, Canada.

出版信息

Hepatology. 1994 Jan;19(1):101-5.

PMID:8276345
Abstract

Hepatic iron and zinc concentrations were determined in 26 consecutive nonalcoholic cirrhotic patients who had previously undergone portacaval shunting and then liver transplantation and 37 control patients. Stainable iron was graded on a scale of 0 to 4; 11 shunt patients and 3 control patients had grade 2 to 4 iron staining. Mean hepatic iron concentration was significantly increased (20.1 +/- 4.1 mumol/gm) in the shunt group compared with the control group (9.1 +/- 2.3 mumol/gm) (normal value, < 35 mumol/gm) (p = .015, Student's t test). Mean hepatic iron index (hepatic iron/age) was 0.5 +/- 0.10 in the shunt group and 0.19 +/- 0.04 in the control group (p = 0.002). One shunt patient had a hepatic iron index of greater than 2. Hepatic zinc was not significantly different between the shunt group (2.42 +/- 0.18 mumol/gm) and the control group (2.56 +/- 0.14 mumol/gm). Serial biopsy specimens were analyzed in 17 cases (6 shunt, 11 controls), and the mean annual rate of iron accumulation was significantly greater in shunt patients (4.75 mumol/gm/yr) than in control cases (0.93 mumol/gm/yr, p = 0.037). Although increased stainable iron was common after portacaval shunting, quantitative iron analysis demonstrated increased hepatic iron concentrations in only 6 of 26 shunt patients and 3 of 37 control patients (p = 0.14, chi 2 test). Quantitative hepatic iron analysis demonstrated in this study that portacaval shunt patients have far less accumulated iron than hemochromatosis patients and are unlikely to have tissue injury resulting from iron overload.

摘要

对26例曾接受门腔分流术并随后接受肝移植的非酒精性肝硬化患者以及37例对照患者测定了肝脏铁和锌的浓度。可染色铁按0至4级分级;11例分流患者和3例对照患者的铁染色为2至4级。与对照组(9.1±2.3μmol/g)(正常值,<35μmol/g)相比,分流组的平均肝脏铁浓度显著升高(20.1±4.1μmol/g)(p = 0.015,Student t检验)。分流组的平均肝脏铁指数(肝脏铁/年龄)为0.5±0.10,对照组为0.19±0.04(p = 0.002)。1例分流患者的肝脏铁指数大于2。分流组(2.42±0.18μmol/g)和对照组(2.56±0.14μmol/g)的肝脏锌含量无显著差异。对17例患者(6例分流患者,11例对照患者)的系列活检标本进行了分析,分流患者的铁蓄积平均年速率(4.75μmol/g/年)显著高于对照患者(0.93μmol/g/年,p = 0.037)。尽管门腔分流术后可染色铁增加很常见,但定量铁分析显示,26例分流患者中只有6例、37例对照患者中只有3例肝脏铁浓度升高(p = 0.14,卡方检验)。本研究中的定量肝脏铁分析表明,门腔分流患者的铁蓄积远少于血色素沉着症患者,不太可能因铁过载导致组织损伤。

相似文献

1
Hepatic iron and zinc concentrations after portacaval shunting for nonalcoholic cirrhosis.非酒精性肝硬化门腔分流术后肝脏铁和锌的浓度
Hepatology. 1994 Jan;19(1):101-5.
2
Hepatic zinc in hemochromatosis.血色素沉着症中的肝脏锌含量
Clin Invest Med. 1991 Feb;14(1):16-20.
3
Study of the secretion of pepsinogen I in cirrhotic humans with and without portacaval shunt.伴有和不伴有门腔分流的肝硬化患者胃蛋白酶原I分泌的研究。
Am J Gastroenterol. 1988 Jan;83(1):37-41.
4
Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.用于治疗顽固性肝硬化腹水的侧侧门腔分流术的实验、临床及代谢结果
J Am Coll Surg. 1997 Jun;184(6):557-70.
5
Determination of hepatic zinc content in chronic liver disease due to hepatitis B virus.乙型肝炎病毒所致慢性肝病肝锌含量的测定
Hepatogastroenterology. 1998 Mar-Apr;45(20):472-6.
6
Liver allograft iron accumulation in patients with and without pretransplantation hepatic hemosiderosis.肝移植受者中,有和没有移植前肝铁沉积患者的肝脏同种异体移植铁蓄积情况。
Liver Transpl. 2002 Apr;8(4):331-9. doi: 10.1053/jlts.2002.30980.
7
Hepatic organic anion transport following portacaval shunt in patients with cirrhosis.肝硬化患者门腔分流术后的肝脏有机阴离子转运
Acta Chir Hung. 1984;25(2):97-106.
8
Increased iron-59 absorption in patients with hepatic cirrhosis.
J Nucl Med. 1966 Aug;7(8):594-602.
9
Portacaval shunt as an experimental model of impaired hepatic release of vitamin A in liver disease.门腔分流术作为肝病中肝脏维生素A释放受损的实验模型。
Gastroenterology. 1991 May;100(5 Pt 1):1379-84.
10
[Minerals in normal and cirrhotic liver. The pathology of mineral dependent athrocytic liver cirrhosis].[正常及肝硬化肝脏中的矿物质。矿物质依赖性红细胞性肝硬化的病理学]
Leber Magen Darm. 1978 Dec;8(6):343-6.

引用本文的文献

1
Disseminated cryptococcosis and hemochromatosis: clues to diagnosis.播散性隐球菌病和血色素沉着症:诊断线索
Autops Case Rep. 2020 Jun 5;10(3):e2020180. doi: 10.4322/acr.2020.180.
2
Hyperammonemia after capecitabine associated with occult impairment of the urea cycle.卡培他滨相关高氨血症伴尿素循环隐匿性损害。
Cancer Med. 2019 May;8(5):1996-2004. doi: 10.1002/cam4.2036. Epub 2019 Apr 11.
3
Serum Concentrations of Selected Heavy Metals in Patients with Alcoholic Liver Cirrhosis from the Lublin Region in Eastern Poland.波兰东部卢布林地区酒精性肝硬化患者血清中某些重金属的浓度
Int J Environ Res Public Health. 2016 Jun 13;13(6):582. doi: 10.3390/ijerph13060582.
4
Normal iron metabolism and the pathophysiology of iron overload disorders.正常铁代谢与铁过载疾病的病理生理学
Clin Biochem Rev. 2006 Feb;27(1):5-16.
5
Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis.HFE基因突变在除遗传性血色素沉着症之外的肝脏疾病中的作用。
Curr Gastroenterol Rep. 1999 Feb-Mar;1(1):30-7. doi: 10.1007/s11894-999-0084-5.
6
Hepatic manifestations of familial patent ductus venosus in adults.成人家族性静脉导管未闭的肝脏表现
Gut. 1999 Sep;45(3):442-5. doi: 10.1136/gut.45.3.442.